Association of Facility Case Volume and Patient Travel Distance With Survival in Laryngeal Squamous Cell Carcinoma.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 42286827.
- Also identified by DOI 10.1002/hed.70350.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Treatment of laryngeal squamous cell carcinoma (SCC) requires specialized expertise. While high-volume facilities demonstrate superior outcomes, the relationship between facility volume and travel distance on survival remains poorly understood. Retrospective cohort study using the National Cancer Database (2004-2022) of adults with laryngeal SCC receiving definitive treatment. Risk-adjusted restricted cubic splines characterized non-linear survival relationships, guiding development of multivariable Cox-proportional hazards regression models. Among 106 700 patients, an inflection point was identified at 10 cases/year. Below this threshold, volume had no effect (HR 1.00 [95% CI: 0.97-1.03]); above it, each doubling was associated with an 11% mortality reduction (HR 0.89 [0.84-0.94]). Travel distance showed a paradoxical protective effect (HR 0.97 [0.96-0.99]), but only in advanced-stage disease (HR 0.96 [0.94-0.97]), with no effect in early-stage disease. A 10-case/year threshold exists for laryngeal SCC care. Early-stage disease can be treated at facilities meeting this, while advanced-stage disease may warrant referral to higher-volume centers.